QS Investors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $14.7M | Sell |
220,550
-27,527
| -11% | -$1.79M | 0.17% | 89 |
|
|
2021
Q1 | $15.7M | Sell |
248,077
-68,317
| -22% | -$4.25M | 0.18% | 90 |
|
|
2020
Q4 | $19.6M | Buy |
316,394
+3,093
| +1% | +$190K | 0.24% | 58 |
|
|
2020
Q3 | $18.9M | Sell |
313,301
-118,939
| -28% | -$7.16M | 0.25% | 60 |
|
|
2020
Q2 | $25.4M | Sell |
432,240
-3,334
| -0.8% | -$199K | 0.35% | 37 |
|
|
2020
Q1 | $24.3M | Buy |
435,574
+9,746
| +2% | +$596K | 0.39% | 39 |
|
|
2019
Q4 | $27M | Buy |
425,828
+31,229
| +8% | +$1.79M | 0.27% | 50 |
|
|
2019
Q3 | $20M | Buy |
394,599
+49,919
| +14% | +$2.35M | 0.22% | 62 |
|
|
2019
Q2 | $15.6M | Buy |
344,680
+65,053
| +23% | +$3.03M | 0.17% | 80 |
|
|
2019
Q1 | $13.3M | Buy |
279,627
+175,672
| +169% | +$8.75M | 0.15% | 95 |
|
|
2018
Q4 | $5.4M | Buy |
103,955
+27,982
| +37% | +$1.5M | 0.07% | 192 |
|
|
2018
Q3 | $4.72M | Sell |
75,973
-3,711
| -5% | -$220K | 0.05% | 297 |
|
|
2018
Q2 | $4.41M | Sell |
79,684
-4,330
| -5% | -$234K | 0.04% | 335 |
|
|
2018
Q1 | $5.31M | Sell |
84,014
-1,353
| -2% | -$87K | 0.05% | 242 |
|
|
2017
Q4 | $5.23M | Sell |
85,367
-2,776
| -3% | -$174K | 0.05% | 280 |
|
|
2017
Q3 | $5.62M | Buy |
88,143
+369
| +0.4% | +$21.5K | 0.05% | 265 |
|
|
2017
Q2 | $4.89M | Buy |
87,774
+13,702
| +18% | +$746K | 0.04% | 317 |
|
|
2017
Q1 | $4.03M | Buy |
74,072
+33,171
| +81% | +$1.82M | 0.03% | 370 |
|
|
2016
Q4 | $2.39M | Sell |
40,901
-2,427
| -6% | -$133K | 0.02% | 571 |
|
|
2016
Q3 | $2.34M | Sell |
43,328
-45,939
| -51% | -$2.95M | 0.02% | 611 |
|
|
2016
Q2 | $6.57M | Sell |
89,267
-78,606
| -47% | -$5.55M | 0.06% | 307 |
|
|
2016
Q1 | $10.7M | Sell |
167,873
-782
| -0.5% | -$49.3K | 0.1% | 191 |
|
|
2015
Q4 | $11.6M | Buy |
168,655
+60,328
| +56% | +$3.99M | 0.11% | 167 |
|
|
2015
Q3 | $6.41M | Sell |
108,327
-219,900
| -67% | -$13.9M | 0.07% | 272 |
|
|
2015
Q2 | $21.8M | Buy |
328,227
+280,200
| +583% | +$18.5M | 0.27% | 80 |
|
|
2015
Q1 | $3.1M | Sell |
48,027
-16,265
| -25% | -$1.02M | 0.04% | 503 |
|
|
2014
Q4 | $3.8M | Buy |
64,292
+8,146
| +15% | +$459K | 0.04% | 429 |
|
|
2014
Q3 | $2.87M | Sell |
56,146
-9,400
| -14% | -$470K | 0.08% | 192 |
|
|
2014
Q2 | $3.18M | Buy |
65,546
+13,592
| +26% | +$670K | 0.09% | 212 |
|
|
2014
Q1 | $2.7M | Sell |
51,954
-4,500
| -8% | -$239K | 0.08% | 211 |
|
|
2013
Q4 | $3M | Sell |
56,454
-1,400
| -2% | -$71.3K | 0.11% | 165 |
|
|
2013
Q3 | $2.68M | Sell |
57,854
-17,446
| -23% | -$766K | 0.12% | 182 |
|
|
2013
Q2 | $3.42M | Buy |
+75,300
| New | +$3.27M | 0.12% | 215 |
|
Other funds holding BMY
QS Investors's BMY Position: Q2 2021 in Review
QS Investors reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2021, selling an estimated $1.79M and leaving 220,550 shares worth $14.7M. The position accounts for 0.17% of the portfolio, ranked #89.
QS Investors first reported a position in BMY in Q2 2013 and has held it in 33 quarters since. The position peaked at $27M in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.
- QS Investors held 220,550 shares of Bristol-Myers Squibb worth $14.7M as of Q2 2021.
- QS Investors sold 27,527 Bristol-Myers Squibb shares in Q2 2021, an estimated $1.79M.
- Bristol-Myers Squibb made up 0.17% of QS Investors's portfolio in Q2 2021, its #89 holding.
- QS Investors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 33 quarters since.
- QS Investors's Bristol-Myers Squibb position peaked at $27M in Q4 2019.
- 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.
Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.